Company Expands Headquarters and National Workforce to Accommodate Rapid Growth IRVINE, Calif.—Laboratory for Advanced Medicine (LAM), a clinical-stage medical technology company developing innovative technologies for the early diagnosis and intervention of cancers, today announced the commercialization of its revolutionary, non-invasive and highly accurate IvyGene test. IvyGene is designed...
from EMS via xlomafota13 on Inoreader https://ift.tt/2mkFLi3
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Editorial introduction No abstract available Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipi...
-
Improvement in postoperative pain control by combined use of intravenous dexamethasone with intravenous dexmedetomidine after interscalene b...
-
Muscle fibrosis, the disruption, of functional parenchyma by stromal elements, is an often overlooked sequela of traumatic muscle injury, ag...
-
Lippincott's Tuesday - 35 Journals - Thank you ! New Recommendations on Sport-Related Concussions: Stronger Methodology, Practical Messa...
-
Abstract Purpose Traumatic subclavian vascular injury (TSVI) is rare but often fatal. The precise diagnosis of TSVI remains challenging ...
-
Abstract A Gram-stain negative, strictly aerobic, non-spore forming, non-motile, rod-shaped bacterium, designated TBBPA-24 T , was isolate...
-
Prognostic impact of Annexin A1 expression in acute myeloid leukemia Mohmoud Gaber, Ali M Kasem, Mohamed Azzazi, Mohamed Tarif, Emad A Yusuf...
-
The Journal of Emergency Medicine from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2OkCOL9
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου